V69I (p.Val69Ile) variant of MFN2 (Mitofusin-2)

V69I (p.Val69Ile) in MFN2 (Mitofusin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as conflicting interpretations in the context of Charcot-Marie-Tooth disease type 2; Hereditary motor and sensory neuropathy with. The available variant effect predictions contribute to a CATVariant prioritization score of 0.55 / 1. The record also includes population frequency data, published literature, and structural context.

V69I (p.Val69Ile) variant details